NDC00002-4182-30: BARICITINIB TABLET.
The BARICITINIB TABLET is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: BARICITINIB TABLETS, ARTHRITIS TREATMENT, 2MG, 30S,. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-688-4626, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | BARICITINIB TABLETS, ARTHRITIS TREATMENT, 2MG, 30S, |
| NSN | 6505-01-688-4626 |
| SPECIAL FEATURES | INDICATED FOR REDUCING THE SIGNS AND SYMPTOMS OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN ADULT PATIENTS WHO HAVE RESPONDED INADEQUATELY TO ONE OR MORE DISEASE MODIFYING ANTI-RHEUMATIC DRUGS; BARICITINIB INHIBITS JANUS KINASES (JAK) AND MODULATES SIGNAL PATHWAYS; 2MG TABLETS; BOTTLE OF 30; STORE AT 20 TO 25 C (68 TO 77 F); EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); KEEP OUT OF REACH OF CHILDREN. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BARICITINIB TABLETS, ARTHRITIS TREATMENT, 2MG, 30S, |